On August 4, 2026, SUNHO BIO-B (02898) announced the appointment of Zheng Zheng Risk Management Consulting Services Limited as an independent internal control advisor, based on a recommendation from the audit committee, to conduct an independent internal control review.

The independent internal control review is proposed to be carried out in three main phases: (i) a preliminary assessment to understand the group's existing internal control framework; (ii) an in-depth review to identify control deficiencies and recommend remedial measures; and (iii) a follow-up review to assess the effectiveness of the implemented remedial measures.

The independent internal control review will cover the internal control systems across all key areas of the group, including financial reporting, procurement, sales, cash management, prepayment management, research and development, outsourcing, contract management, compliance with listing rules, and other significant operational and governance processes.